Gruber & McBaine Capital Management’s iRadimed IRMD Stock Holding History

Gruber & McBaine Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$2.39M	Buy	102,750 +2,050	+2%	+$37.4K	0.65%	50
2015 Q1	$1.53M	Buy	100,700 +20,500	+26%	+$303K	0.41%	75
2014 Q4	$1.03M	Buy	80,200 +5,600	+8%	+$48.4K	0.29%	113
2014 Q3	$523K	Buy	+74,600	New	+$675K	0.15%	153

Other funds holding IRMD

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gruber & McBaine Capital Management's IRMD Position: Q2 2015 in Review

Gruber & McBaine Capital Management increased its iRadimed (IRMD) stake by 2% in Q2 2015, buying an estimated $37.4K and bringing the position to 102,750 shares worth $2.39M. The position accounts for 0.65% of the portfolio, ranked #50.

Gruber & McBaine Capital Management first reported a position in IRMD in Q3 2014 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold IRMD as of Q2 2015.

Gruber & McBaine Capital Management held 102,750 shares of iRadimed worth $2.39M as of Q2 2015.
Gruber & McBaine Capital Management bought 2,050 iRadimed shares in Q2 2015, an estimated $37.4K.
iRadimed made up 0.65% of Gruber & McBaine Capital Management's portfolio in Q2 2015, its #50 holding.
Gruber & McBaine Capital Management first reported a position in iRadimed in Q3 2014 and has held it in 4 quarters since.
39 funds tracked by Wall St. Rank held iRadimed as of Q2 2015.

Based on Gruber & McBaine Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.